SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
XOMA. Bull or Bear?
An SI Board Since July 1996
Posts SubjectMarks Bans Symbol
17367 72 0 XOMA
Emcee:  Olu Emuleomo Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
16567George, what are your thoughts on today's trading action? Did you see the aBluegreen-1/31/2004
16566Enjoy? Give it a rest, Biostock1. PardoRobert S.-1/30/2004
16565WOW!!!!!!!!!!!!!!!!! Can one say that Raptiva immunoneutralizes lfa-1????? WhaBluegreen-1/29/2004
16564bspinoza has posted both Amevive and Raptiva U.S. scrips at the swamp. Differenaknahow-1/29/2004
16563How do you read them and WHERE are they from??? Are they TOTAL scripts written Bluegreen-1/29/2004
16562Any comments on the bright light Spinoza cast on the scrip sales of Amevive and aknahow-1/28/2004
16561Bob, so what did you think of the development at Baxter??? Do you think he evenBluegreen-1/27/2004
16560Blue, for you> OBJECTIVE: Lung damage is the most common cause of death in cyRobert K.-1/27/2004
16559Do you think Neuprex might have saved his job? Did he even know they had NeupreBluegreen-1/27/2004
16558ALERT!!!!!!!!!!!!! ALERT!!!!!!!!!!!!!!>>>>>>>>>>Bluegreen-1/27/2004
16557Blue>you might want to read up more on cf. One also has to wonder about nektaRobert K.-1/26/2004
16556Blue> This is right on target IMO "Thus, in pediatric CF patients, BPI-Robert K.-1/25/2004
16555Bluegreen> this is the first post and the FIRST time I have EVER seen someoneRobert K.-1/23/2004
16554XOMA Advances into Phase II Acne Clinical Trials with XMP.629 Thursday January 2nigel bates-1/22/2004
16553I agree, but as with Amevive, duration, is going to be the key to convincing thaknahow-1/21/2004
16552George, if you are young or even middle aged with acne which would you rather doBluegreen-1/21/2004
16551Cacaito did you see my last post about CF???? Why don't YOU start a probe sBluegreen-1/21/2004
16550Bob, I thought you might need a little education about CF and ANCA.LOL Enjoy>Bluegreen-1/21/2004
16549Contra Costa Times Jan 6 snip. Now I see why so often people insert a request fLance Bredvold-1/18/2004
16548We will know sooner or later (most probably later) eom.Cacaito-1/16/2004
16547Cacaito, I found him in the Octopus garden next to the Walrus coo coo ka chew.&gBluegreen-1/16/2004
16546Cacaito what about this???? Scroll down to the antibacterial peptide part>&gBluegreen-1/16/2004
16545Cacaito, great find! What is going on???? All I could find was this>>>Bluegreen-1/16/2004
16544Another piece from Gw groupies at 'hoo: THE PATENT !!! Apparently, as per tCacaito-1/16/2004
16543RKK ALERT, FISHIER than cod: same doc !!! Inhibition of endotoxin effects on cuCacaito-1/16/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News